Establishment of the Dutch Nationwide, Interdisciplinary Infrastructure and Biobank for Fundamental and Translational Ovarian Cancer Research: Archipelago of Ovarian Cancer Research.
Saved in:
| Title: | Establishment of the Dutch Nationwide, Interdisciplinary Infrastructure and Biobank for Fundamental and Translational Ovarian Cancer Research: Archipelago of Ovarian Cancer Research. |
|---|---|
| Authors: | Zelisse HS; Department of Pathology, Cancer Center Amsterdam, Amsterdam Reproduction and Development Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands, h.s.zelisse@amsterdamumc.nl., van Gent MDJM; Department of Gynaecologic Oncology, Centre for Gynaecologic Oncology Amsterdam, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., de Ridder S; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van der Aa MA; Department of Research and Development, IKNL - Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands., van Altena AM; Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands., Bart J; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Belien JAM; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Boere IA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Bosch SL; Department of Pathology, Laboratory for Pathology and Medical Microbiology (Stichting PAMM), Eindhoven, The Netherlands., Broeks A; Department of CFMPB (Core Facility - Molecular Pathology and Biobanking), the Netherlands Cancer Institute, Amsterdam, The Netherlands., Bulten J; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Collée M; Department of Clinical Genetics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Groenendijk FH; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Jansen MPHM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Jonges TGN; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Kooreman LFS; Department of Pathology and GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands., de Kroon CD; Department of Obstetrics and Gynaecology, Leiden University Medical Center, Leiden, The Netherlands., Lambrechts S; Department of Obstetrics and Gynaecology, Maastricht University Medical Centre, Maastricht, The Netherlands., Lok CAR; Department of Gynaecological Oncology, Centre for Gynaecologic Oncology Amsterdam, Antoni van Leeuwenhoek - the Netherlands Cancer Institute, Amsterdam, The Netherlands., Piek JM; Department of Obstetrics and Gynaecology, Catharina Hospital, Catharina Cancer Institute, Eindhoven, The Netherlands., Reyners AKL; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Roes EM; Department of Gynecologic Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Simons M; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Wisman GBA; Department of Gynaecologic Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Yigit R; Department of Obstetrics and Gynaecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Zweemer RP; Department of Gynaecological Oncology, Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Mom CH; Department of Gynaecologic Oncology, Centre for Gynaecologic Oncology Amsterdam, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van de Vijver MJ; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Dijk F; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. |
| Corporate Authors: | Archipelago of Ovarian Cancer Research Consortium |
| Source: | Gynecologic and obstetric investigation [Gynecol Obstet Invest] 2022; Vol. 87 (6), pp. 389-397. Date of Electronic Publication: 2022 Nov 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 7900587 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-002X (Electronic) Linking ISSN: 03787346 NLM ISO Abbreviation: Gynecol Obstet Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1423-002X |
|---|---|
| DOI: | 10.1159/000528330 |
